Project Details
Description
A Twelve-Month, Phase II, Randomized, Open-Label, Multi-Center, Dose-Ranging Study of Weekly ALTU-238 (Somatropin) as Compared with Daily Nutropin AQ (Somatropin) in Prepubertal Children with Growth Hormone Deficiency
| Status | Finished |
|---|---|
| Effective start/end date | 11/4/08 → 9/11/09 |
Funding
- ALTUS PHARMACEUTICALS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.